Nutrition and the HIV-associated lipodystrophy syndrome
CR Loonam, A Mullen - Nutrition research reviews, 2012 - cambridge.org
HIV-associated lipodystrophy syndrome (HALS), comprising metabolic and morphological
alterations, is a known side effect of highly active antiretroviral therapy (HAART). Evidence …
alterations, is a known side effect of highly active antiretroviral therapy (HAART). Evidence …
Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
Background: Switching from boosted protease inhibitors (PI/r) to raltegravir (RAL) results in a
better plasma lipid profile than continuing PI/r. Whether this strategy affects plasma …
better plasma lipid profile than continuing PI/r. Whether this strategy affects plasma …
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir
GA McComsey, D Kitch, ES Daar, C Tierney, NC Jahed… - Aids, 2012 - journals.lww.com
Background: The effect of specific antiretrovirals on inflammation is unclear. Methods:
A5224s was a substudy of A5202, which randomized HIV-infected treatment-naïve patients …
A5224s was a substudy of A5202, which randomized HIV-infected treatment-naïve patients …
[PDF][PDF] Antiretroviral molecules and cardiovascular diseases
D Gibellini, M Borderi, A Clò, S Morini… - New …, 2012 - newmicrobiologica.org
Antiretroviral therapy has effectively tackled HIV replication and prevented the development
of AIDS-related complications in the majority of HIV-positive patients. This pharmacological …
of AIDS-related complications in the majority of HIV-positive patients. This pharmacological …
Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy
A Biron, C Bobin-Dubigeon, C Volteau… - AIDS research and …, 2012 - liebertpub.com
Abstract Treatment of HIV infection with highly active antiretroviral therapy can induce
metabolic complications and increase the risk of developing the metabolic syndrome (MS) …
metabolic complications and increase the risk of developing the metabolic syndrome (MS) …
[PDF][PDF] Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
E Martınez, PM D'Albuquerque, JM Llibre, F Gutierrez… - AIDS, 2012 - academia.edu
Background: Switching from boosted protease inhibitors (PI/r) to raltegravir (RAL) results in a
better plasma lipid profile than continuing PI/r. Whether this strategy affects plasma …
better plasma lipid profile than continuing PI/r. Whether this strategy affects plasma …
Documento de consenso de Gesida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia …
Panel de Expertos de Gesida y Plan Nacional … - … y microbiología clínica, 2012 - Elsevier
Este documento de consenso ha sido elaborado por un panel de expertos de Gesida y de la
Secretaría del Plan Nacional sobre el Sida. Para ello se han revisado los resultados de …
Secretaría del Plan Nacional sobre el Sida. Para ello se han revisado los resultados de …
Initiation of an abacavir-containing regimen in HIV-infected adults is associated with a smaller decrease in inflammation and endothelial activation markers compared …
CO Hileman, DA Wohl, DJ Tisch… - AIDS research and …, 2012 - liebertpub.com
Abacavir has been associated with myocardial infarction in several studies. This may be
related to inflammation and endothelial cell activation. We compared changes in …
related to inflammation and endothelial cell activation. We compared changes in …
Effects of highly active antiretroviral therapy on platelet activating factor metabolism in naive HIV-infected patients: ii) study of the abacavir/lamivudine/efavirenz …
M Chini, AB Tsoupras, N Mangafas… - International journal …, 2012 - journals.sagepub.com
Human Immunodeficiency Virus (HIV)-infected patients are at increased risk for
cardiovascular diseases partly due to chronic inflammation. Some antiretroviral drugs and …
cardiovascular diseases partly due to chronic inflammation. Some antiretroviral drugs and …
Effect of abacavir on acute changes in biomarkers associated with cardiovascular dysfunction
Background This study examined the effect of abacavir on acute changes in biomarkers
associated with cardiovascular dysfunction. Methods Among the Study to Understand the …
associated with cardiovascular dysfunction. Methods Among the Study to Understand the …